Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Update on phase I studies in advanced pancreatic adenocarcinoma. Hunting in darkness?

JOP : Journal of the pancreas - 10 Jul 2013

Strimpakos Alexios S, Saif Muhammad Wasif

Abstract excerpt

Over the last twenty years, there is a limited number of effective cytotoxic or biological agents that managed to get approval in advanced pancreatic ductal adenocarcinoma. Despite numerous trials, investments in translational research and generally in health care, the survival of pancreatic cancer patients has improved by a few only months. This disappointing reality necessitates a better understanding of the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Clinical Trials, Phase I as Topic
Share to Deoxycytidine
Share to Furans

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gemcitabine

Share to Hyaluronoglucosaminidase

Share to Pancreatic Neoplasms

Share to Polyethylene Glycols

Share to ras Proteins

Source

Identifiers

PMID: 23846926
DOI: 10.6092/1590-8577/1664

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Update on phase I studies in advanced pancreatic adenocarcinoma. Hunting in darkness?PMID 23846926Read ↗

Recent advances in the treatment of pancreatic cancerSemantic proximity Read ↗

Pancreatic acinar cell carcinoma: A comprehensive review.Semantic proximity Read ↗

Advances in the Treatment of Pancreatic CancerSemantic proximity Read ↗

Target and Gene-Based Therapeutic Strategies against Pancreatic Cancer: Current and Future ProspectsSemantic proximity Read ↗

Current and future therapies for advanced pancreatic cancer.Semantic proximity Read ↗

Navigating the complexities of pancreatic ductal adenocarcinoma: A review on therapeutic models and RAS inhibitors.Semantic proximity Read ↗

Pancreatic ductal adenocarcinoma treatment--the past, present, and future.Semantic proximity Read ↗

Pancreatic cancer: optimizing treatment options, new, and emerging targeted therapies.Semantic proximity Read ↗

Treating Pancreatic Ductal Adenocarcinoma: The Targeted Revolution is Here.Semantic proximity Read ↗

Emerging drugs in the treatment of pancreatic cancer.Semantic proximity Read ↗

Current Treatment Methods in Pancreatic Cancer and the Need for ImprovementSemantic proximity Read ↗

Systemic therapy for advanced pancreatic cancer: individualising cytotoxic therapy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.